Skip to main content

Covid-19 in pediatric patients

  1. Although the severity of coronavirus disease 2019 (COVID-19) tends to be lower in children, it can still lead to severe illness, particularly among those with chronic medical conditions. While remdesivir (RDV)...

    Authors: Abigail Schulz, Natalie Huynh, Margaret Heger and Mustafa Bakir
    Citation: Molecular and Cellular Pediatrics 2024 11:2
  2. Multisystem inflammatory syndrome in children associated with COVID-19 (MIS-C) is a late complication of pediatric COVID-19, which follows weeks after the original SARS-CoV-2 infection, regardless of its sever...

    Authors: Adam Klocperk, Marketa Bloomfield, Zuzana Parackova, Ludovic Aillot, Jiri Fremuth, Lumir Sasek, Jan David, Filip Fencl, Aneta Skotnicova, Katerina Rejlova, Martin Magner, Ondrej Hrusak and Anna Sediva
    Citation: Molecular and Cellular Pediatrics 2023 10:15
  3. The SARS-CoV-2 pandemic has caused significant pulmonary morbidity and mortality in the adult population. Children and adolescents typically show milder symptoms; however, a relevant proportion of them report ...

    Authors: Sebastian Felix Nepomuk Bode, Anja Schwender, Monika Toth, Christine Kaeppler-Schorn, Ute Siebeneich, Joachim Freihorst, Ales Janda and Dorit Fabricius
    Citation: Molecular and Cellular Pediatrics 2023 10:10